Atreca
Xiaobin Tang has experience as a Senior Scientist at Atreca, Inc., starting in 2016. Prior to that, they worked as Academic Staff at Stanford University starting in 2010. At Stanford, they conducted research on the molecular and cellular mechanisms of lupus glomerulonephritis, specifically focusing on the role of NKT cells and the identification of drugs that can inhibit pro-inflammatory cytokines and reduce antibody productions in patients with systemic lupus erythematosus (SLE).
Xiaobin Tang pursued a Doctor of Philosophy (Ph.D.) degree with a specialization in Biochemistry and Molecular Biology from Peking Union Medical College. No specific start or end years were provided for this education.
Atreca
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics.